FST.L Regulatory News (FST)

24 Jan 2008 07:00

Embargoed Release: 07:00hrs Thursday 24 January 2008

Nanoscience Inc. (`The Group') Toumaz Technology Awarded ISO 13485 Medical Device Quality Management Certification for Sensium¢â€ž¢ Wireless Body Monitoring Platform Toumaz's commitment to the highest quality management standard required for medical device manufacture recognised by independent accrediting body

Nanoscience Inc, the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary Toumaz Technology Limited (`Toumaz') has received ISO 13485:2003 certification for its quality management system. ISO 13485 is the regulatory standard for the international medical industry and is closely related to ISO 9000. Toumaz (a leading provider of ultra-low power wireless infrastructure for body monitoring solutions) was assessed and certified as meeting the requirements of this strategically significant standard by independent body SGS, the world's leading verification and certification body.

ISO 13485 is a regulatory requirement in a number of international markets for the manufacture of medical devices, and forms the cornerstone for the CE certification of medical products in the EU. Meeting the ISO quality management standard is a crucial milestone in the ongoing commercialisation of Sensium¢â€ž¢, Toumaz's breakthrough ultra-low power wireless platform for the development of non-intrusive body monitors for healthcare and lifestyle markets. In November 2007, Toumaz took the top honours in the Electronics category of the prestigious Innovation in Engineering Awards - given by The Institution of Engineering and Technology - in recognition of the groundbreaking innovation of the Sensium as an enabling technology for highly valuable medical applications.

Keith Errey, COO, Toumaz, commented:

"We are delighted that Toumaz has been awarded the important ISO 13485 certification, which demonstrates our absolute commitment to quality throughout the product cycle including the manufacture of medical devices, and which will offer significant benefits to our customers."

The unique combination of ultra-low power wireless and signal processing in one small System-on-Chip (SOC) allows the economies of scale of the semiconductor industry to be harnessed to provide highly functional, robust, low cost, disposable and non-intrusive monitors for a wide range of healthcare applications.

The Sensium sensor interface and transceiver platform enables real-time, intelligent, ultra-low power wireless monitoring of multiple vital signs - such as ECG, heart rate, body temperature, respiration and physical activity (via a 3-axis accelerometer) - and is currently being developed in both disposable and non-disposable body monitoring products.

- Ends -

About Toumaz Technology (www.toumaz.com)

Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - the Sensium¢â€ž¢ - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx)¢â€ž¢ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Further information:Guy Spelman Nanoscience Inc. 07767 338 967 Andrew Tan Hansard Group 020 7245 1100 www.hansardgroup.co.uk Tim Goodman Ambrian Partners Limited 0207 776 6400 About Nanoscience Inc.:

Nanoscience is a specialist niche investor in emerging technologies with a strong commercial proposition from within the medical technology and semiconductor sectors.